NCT00238641View on ClinicalTrials.gov

"DOES MYOBLOC™ IMPROVE FUNCTIONAL HAND USE IN YOUNG CHILDREN WITH A HYPERTONIC UPPER EXTREMITY?"

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

January 31, 2002

Study Completion Date

May 31, 2005

Conditions

Cerebral Palsy

Interventions

DRUG

Botulinum Toxin type B

Trial Locations (1)

94305-5235

Stanford University, Stanford

Sponsors

Collaborators (1)

Elan Pharmaceuticals

All Listed Sponsors

collaborator

Elan Pharmaceuticals

INDUSTRY

lead

Stanford University

OTHER

NCT00238641 - "DOES MYOBLOC™ IMPROVE FUNCTIONAL HAND USE IN YOUNG CHILDREN WITH A HYPERTONIC UPPER EXTREMITY?" | Biotech Hunter | Biotech Hunter